Full Text
The Expected Impact of Oncology Biosimilars In Brazil And Mexico- Payers and Oncologists Consider The cost-Effectiveness of These Cheaper Alternatives

Abstract

Authors

S. Zevallos A. Ribeiro J. Cox

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×